logo
FOREWORD
Antiplatelet and Anticoagulant Agents in Cardiovascular Disease: Basic Research and Clinical Applications
Antithrombotic Drugs in Vascular Medicine: A Historical Perspective
Aspirin and Other Cyclooxygenase Inhibitors: New Therapeutic Insights
P2Y12, A New Platelet ADP Receptor, Target of Clopidogrel
GPIIb/IIIa Antagonists and Other Anti-Integrins
Orally Active Direct Thrombin Inhibitors
The Present and Future of Heparin, Low Molecular Weight Heparins, Pentasaccharide, and Hirudin for Venous Thromboembolism and Acute Coronary Syndromes
Role of Platelets in the Pathophysiology of Acute Coronary Syndrome
Combined Antithrombotic Therapy for Acute Coronary Syndrome
Low-Dose Aspirin for Primary Prevention of Cardiovascular Disease *
Tissue Factor in Acute Coronary Syndromes
The Role of the Tissue Factor-Thrombin Pathway in Cardiac Ischemia-Reperfusion Injury
rFVIIai in Acute Coronary Syndromes
Targeting Tissue Factor as an Antithrombotic Strategy